Adenosine/A2B Receptor Signaling Ameliorates the Effects of Aging and Counteracts Obesity.


Journal

Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170

Informations de publication

Date de publication:
07 07 2020
Historique:
received: 01 08 2019
revised: 15 03 2020
accepted: 08 06 2020
pubmed: 27 6 2020
medline: 10 11 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

The combination of aging populations with the obesity pandemic results in an alarming rise in non-communicable diseases. Here, we show that the enigmatic adenosine A2B receptor (A2B) is abundantly expressed in skeletal muscle (SKM) as well as brown adipose tissue (BAT) and might be targeted to counteract age-related muscle atrophy (sarcopenia) as well as obesity. Mice with SKM-specific deletion of A2B exhibited sarcopenia, diminished muscle strength, and reduced energy expenditure (EE), whereas pharmacological A2B activation counteracted these processes. Adipose tissue-specific ablation of A2B exacerbated age-related processes and reduced BAT EE, whereas A2B stimulation ameliorated obesity. In humans, A2B expression correlated with EE in SKM, BAT activity, and abundance of thermogenic adipocytes in white fat. Moreover, A2B agonist treatment increased EE from human adipocytes, myocytes, and muscle explants. Mechanistically, A2B forms heterodimers required for adenosine signaling. Overall, adenosine/A2B signaling links muscle and BAT and has both anti-aging and anti-obesity potential.

Identifiants

pubmed: 32589947
pii: S1550-4131(20)30307-7
doi: 10.1016/j.cmet.2020.06.006
pmc: PMC7437516
mid: NIHMS1607842
pii:
doi:

Substances chimiques

Receptor, Adenosine A2B 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-70.e7

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK109574
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK122796
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133900
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests T.G., L.R.-S., F.C., D.W., J.N., A.H., S.H.-B., B.K.F., and A.P. have filed an application for patenting A2B agonist treatment of musculoskeletal disorders.

Références

Sci Signal. 2009 Dec 01;2(99):ra78
pubmed: 19952371
Physiol Rev. 2013 Jul;93(3):993-1017
pubmed: 23899560
J Nutr Health Aging. 2008 Aug-Sep;12(7):427-32
pubmed: 18615224
Circulation. 1998 Jul 7;98(1):6-8
pubmed: 9665052
Br J Pharmacol. 2014 Dec;171(24):5650-64
pubmed: 25073922
Exp Gerontol. 2005 Dec;40(12):959-65
pubmed: 16213688
J Clin Invest. 2014 May;124(5):2099-112
pubmed: 24713652
Arch Physiol Biochem. 2011 May;117(2):47-56
pubmed: 21158485
Purinergic Signal. 2015 Sep;11(3):389-407
pubmed: 26126429
J Pharmacol Exp Ther. 2013 Feb;344(2):426-35
pubmed: 23149337
Oncotarget. 2018 Feb 6;9(17):13593-13611
pubmed: 29568380
Am J Physiol. 1994 Sep;267(3 Pt 1):E475-84
pubmed: 7943228
Nat Med. 2013 May;19(5):631-4
pubmed: 23603813
Pharmacol Rev. 2001 Dec;53(4):527-52
pubmed: 11734617
Nature. 2012 Jan 11;481(7382):463-8
pubmed: 22237023
PLoS One. 2012;7(7):e40584
pubmed: 22848385
Compr Physiol. 2015 Jul 1;5(3):1027-59
pubmed: 26140708
Cell Metab. 2011 Mar 2;13(3):238-40
pubmed: 21356513
J Exp Med. 2005 May 2;201(9):1397-405
pubmed: 15867092
Nat Med. 2013 May;19(5):635-9
pubmed: 23603815
J Nutr Health Aging. 2012 Jan;16(1):67-77
pubmed: 22238004
J Appl Physiol (1985). 1995 Jan;78(1):172-8
pubmed: 7713808
J Am Geriatr Soc. 2014 Jul;62(7):1324-8
pubmed: 24962132
Neuropsychopharmacology. 2007 Nov;32(11):2249-59
pubmed: 17356572
J Biol Chem. 2010 Dec 10;285(50):39271-88
pubmed: 20926384
J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):349-369
pubmed: 28432755
Cell Metab. 2013 May 7;17(5):798-805
pubmed: 23663743
Sci Rep. 2017 Feb 08;7:42323
pubmed: 28176863
Diabetes. 2014 Mar;63(3):850-66
pubmed: 24194503
Age (Dordr). 2013 Dec;35(6):2367-75
pubmed: 23407994
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
Cell Rep. 2013 Feb 21;3(2):319-27
pubmed: 23375372
Elife. 2018 May 04;7:
pubmed: 29726815
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
Nat Rev Endocrinol. 2018 Sep;14(9):513-537
pubmed: 30065268
Purinergic Signal. 2008 Dec;4(4):287-303
pubmed: 18443746
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449-57
pubmed: 27239426
Age (Dordr). 2016 Feb;38(1):23
pubmed: 26846415
Nature. 2014 Feb 20;506(7488):316-21
pubmed: 24522534
J Biol Chem. 2004 Jul 2;279(27):28756-65
pubmed: 15123695
Pharmacol Rev. 1998 Sep;50(3):413-92
pubmed: 9755289
Cell Rep. 2019 Jul 16;28(3):792-803.e4
pubmed: 31315055
Nat Rev Endocrinol. 2012 Apr 03;8(8):457-65
pubmed: 22473333
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14289-94
pubmed: 25225406
J Cereb Blood Flow Metab. 1985 Dec;5(4):584-90
pubmed: 4055928
Eur J Pharmacol. 2008 Nov 12;597(1-3):92-101
pubmed: 18789919
J Gerontol A Biol Sci Med Sci. 2006 Jan;61(1):72-7
pubmed: 16456196
Cell Metab. 2015 Oct 6;22(4):546-59
pubmed: 26445512
Circulation. 2005 Aug 2;112(5):674-82
pubmed: 16043637
Acta Physiol Scand. 2000 Aug;169(4):283-90
pubmed: 10951119
J Neurosci Res. 1995 Dec 15;42(6):818-28
pubmed: 8847743
Mol Cell Endocrinol. 2017 Apr 15;445:109-117
pubmed: 27531569
J Biol Chem. 2002 Sep 20;277(38):35402-10
pubmed: 12140284
Obesity (Silver Spring). 2016 Oct;24(10):2092-100
pubmed: 27515773
Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):388-95
pubmed: 18395429
Br J Clin Pharmacol. 1989 Jan;27(1):31-8
pubmed: 2565118
Br J Clin Pharmacol. 1992 Jan;33(1):83-7
pubmed: 1311596
J Vis Exp. 2013 Jun 02;(76):
pubmed: 23770643
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):743-750
pubmed: 30105585
Diabetes Metab Res Rev. 2011 Mar;27(3):286-97
pubmed: 21309058
N Engl J Med. 2009 Apr 9;360(15):1500-8
pubmed: 19357405
Nat Med. 2015 Apr;21(4):389-94
pubmed: 25774848
J Neurochem. 2004 Feb;88(3):726-34
pubmed: 14720222
JAMA. 1999 Feb 10;281(6):558-60
pubmed: 10022113
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5618-23
pubmed: 15800038
Br J Clin Pharmacol. 1982 Dec;14(6):821-6
pubmed: 6129882
Cell Metab. 2018 Sep 4;28(3):476-489.e5
pubmed: 30017353
Int J Obes (Lond). 2016 Mar;40(3):434-442
pubmed: 26435323
Annu Rev Pharmacol Toxicol. 2015;55:207-27
pubmed: 25149919
J Vis Exp. 2014 Apr 08;(86):
pubmed: 24747722
Longev Healthspan. 2014 Dec 01;3(1):9
pubmed: 25520782
FEBS J. 2019 Jul;286(14):2753-2768
pubmed: 30963699
Cell Metab. 2015 Jan 6;21(1):33-8
pubmed: 25565203
Cell Metab. 2011 Aug 3;14(2):272-9
pubmed: 21803297
Circulation. 2007 Mar 27;115(12):1581-90
pubmed: 17353435
Exerc Sport Sci Rev. 2010 Jan;38(1):31-5
pubmed: 20016297
Physiol Rev. 2011 Oct;91(4):1447-531
pubmed: 22013216
Nat Commun. 2017 Sep 14;8(1):542
pubmed: 28912485
Sci Transl Med. 2014 Jul 30;6(247):247ra103
pubmed: 25080478
Diabetes. 2012 Jun;61(6):1315-22
pubmed: 22618766
Adipocyte. 2016 May 18;5(2):153-62
pubmed: 27386159
Nature. 2014 Dec 18;516(7531):395-9
pubmed: 25317558
Cell Metab. 2010 Apr 7;11(4):248-52
pubmed: 20374955
J Immunol. 2008 Jun 1;180(11):7212-20
pubmed: 18490720
J Anat. 1972 May;112(Pt 1):35-9
pubmed: 5086212
J Physiol. 2015 Nov 1;593(21):4713-27
pubmed: 26400207
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Pharmacol Rev. 2011 Mar;63(1):1-34
pubmed: 21303899
Ageing Res Rev. 2017 May;35:200-221
pubmed: 27702700
Mech Ageing Dev. 2005 Sep;126(9):913-22
pubmed: 15885745
Adipocyte. 2014 Jan 1;3(1):4-9
pubmed: 24575363
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Cell Metab. 2018 Oct 2;28(4):631-643.e3
pubmed: 30078553
J Biol Chem. 2001 May 25;276(21):18345-51
pubmed: 11278325
Aging Cell. 2014 Feb;13(1):39-48
pubmed: 23919652
Nat Rev Endocrinol. 2017 Jan;13(1):26-35
pubmed: 27616452
J Inflamm (Lond). 2018 May 9;15:9
pubmed: 29760587
Cell. 2018 Feb 8;172(4):719-730.e14
pubmed: 29398112
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10937-10942
pubmed: 31085638
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8606-11
pubmed: 10890919
Genes Dev. 2005 Sep 1;19(17):1986-99
pubmed: 16107615
Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E1-17
pubmed: 22354781
Cell Metab. 2015 Jul 7;22(1):25-30
pubmed: 26154051
N Engl J Med. 2009 Apr 9;360(15):1518-25
pubmed: 19357407

Auteurs

Thorsten Gnad (T)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany.

Gemma Navarro (G)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, Spain; Centro de Investigación en Red, Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos III, Madrid, Spain.

Minna Lahesmaa (M)

Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland.

Laia Reverte-Salisa (L)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany.

Francesca Copperi (F)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany.

Arnau Cordomi (A)

Laboratory of Computational Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.

Jennifer Naumann (J)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany.

Aileen Hochhäuser (A)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany.

Saskia Haufs-Brusberg (S)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany.

Daniela Wenzel (D)

Institute of Physiology I, Life&Brain Center, Medical Faculty, University of Bonn, 53105 Bonn, Germany; Department of Systems Physiology, Medical Faculty, Ruhr University Bochum, Bochum, Germany.

Frank Suhr (F)

Molecular and Cellular Sport Medicine, German Sport University Cologne, Cologne, Germany; Exercise Physiology Research Group, Biomedical Sciences Group, KU Leuven, Leuven, Belgium.

Naja Zenius Jespersen (NZ)

Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Camilla Scheele (C)

Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Volodymyr Tsvilovskyy (V)

Institute of Pharmacology, Ruprecht-Karls University, Heidelberg, Germany.

Christian Brinkmann (C)

Department of Preventive and Rehabilitative Sport Medicine, German Sport University Cologne, Cologne, Germany.

Joern Rittweger (J)

Department of Muscle and Bone Metabolism, German Aerospace Center (DLR), Institute of Aerospace Medicine, Cologne, Germany.

Christian Dani (C)

Université Côte d'Azur, CNRS, Inserm, iBV, Faculté de Médecine, 06107 Nice Cedex 2, France.

Mathias Kranz (M)

Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Leipzig, Germany.

Winnie Deuther-Conrad (W)

Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Leipzig, Germany.

Holger K Eltzschig (HK)

Department of Anesthesiology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, TX, USA.

Tarja Niemi (T)

Department of Plastic and General Surgery, Turku University Hospital, Turku, Finland.

Markku Taittonen (M)

Department of Anesthesiology, Turku University Hospital, Turku, Finland.

Peter Brust (P)

Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Leipzig, Germany.

Pirjo Nuutila (P)

Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland.

Leonardo Pardo (L)

Laboratory of Computational Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.

Bernd K Fleischmann (BK)

Institute of Physiology I, Life&Brain Center, Medical Faculty, University of Bonn, 53105 Bonn, Germany.

Matthias Blüher (M)

Department of Medicine, University of Leipzig, Leipzig, Germany.

Rafael Franco (R)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, Spain; Centro de Investigación en Red, Enfermedades Neurodegenerativas (CiberNed), Instituto de Salud Carlos III, Madrid, Spain.

Wilhelm Bloch (W)

Molecular and Cellular Sport Medicine, German Sport University Cologne, Cologne, Germany.

Kirsi A Virtanen (KA)

Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland; Institute of Public Health and Clinical Nutrition, University of Eastern Finland (UEF), Kuopio, Finland.

Alexander Pfeifer (A)

Institute of Pharmacology and Toxicology, University Hospital, University of Bonn, 53127 Bonn, Germany. Electronic address: alexander.pfeifer@uni-bonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH